Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-14 Greenstreet Yvonne Chief Executive Officer Sale −38 $260.57 $10K 81,619
2025-02-14 Greenstreet Yvonne Chief Executive Officer Sale −47 $261.45 $12K 81,572
2025-02-14 Greenstreet Yvonne Chief Executive Officer Sale −21 $263.33 $6K 81,551
2025-02-14 Greenstreet Yvonne Chief Executive Officer Sale −25 $264.87 $7K 81,526
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −217 $252.50 $55K 33,536
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −239 $253.37 $61K 33,297
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −160 $254.35 $41K 33,137
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −68 $255.56 $17K 33,069
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −78 $256.29 $20K 32,991
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −37 $257.51 $10K 32,954
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −47 $258.07 $12K 32,907
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −17 $259.72 $4K 32,890
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −30 $260.57 $8K 32,860
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −37 $261.45 $10K 32,823
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −17 $263.33 $4K 32,806
2025-02-14 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −20 $264.87 $5K 32,786
2025-02-14 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −145 $252.50 $37K 14,839
2025-02-14 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −164 $253.37 $42K 14,675
2025-02-14 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −110 $254.35 $28K 14,565
2025-02-14 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −47 $255.56 $12K 14,518

Page 37 of 41 · 816 trades